Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs. It also provides outpatient community-based services, such as community-based programs that are designed to offer therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorder. In addition, the company provides mental health services; rehabilitation services comprising relapse prevention and social integration services, as well as vocational opportunities; acute services for patients at risk to themselves or others, as well as crisis intervention and treatment of behavioral emergencies; and long-term and non-acute care services for adults suffering from mental illness, addiction, learning disability, or brain injury. Further, it provides education and children's services for children and young people with special educational needs; adult and elderly care services; and care first services for employees. As of December 31, 2017, the company operated a network of 582 behavioral healthcare facilities with approximately 17,800 beds in the United States, the United Kingdom, and Puerto Rico. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Industry, Sector and Symbol
Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryHealth Care Facilities
SectorMedical
Phone615-861-6000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.84 billion
Profitability
Miscellaneous
Employees40,600
OptionableOptionable
Acadia Healthcare (NASDAQ:ACHC) Frequently Asked Questions
What is Acadia Healthcare's stock symbol?
Acadia Healthcare trades on the NASDAQ under the ticker symbol "ACHC."
How were Acadia Healthcare's earnings last quarter?
Acadia Healthcare Company Inc (NASDAQ:ACHC) issued its quarterly earnings data on Monday, November, 5th. The company reported $0.55 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.64 by $0.09. The firm had revenue of $760.90 million for the quarter, compared to analysts' expectations of $760.46 million. Acadia Healthcare had a return on equity of 7.71% and a net margin of 7.43%. The firm's revenue was up 6.2% on a year-over-year basis. During the same period last year, the company earned $0.58 earnings per share. View Acadia Healthcare's Earnings History.
When is Acadia Healthcare's next earnings date?
What guidance has Acadia Healthcare issued on next quarter's earnings?
Acadia Healthcare issued an update on its FY18 earnings guidance on Monday, November, 5th. The company provided EPS guidance of $2.25-2.27 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.52. The company issued revenue guidance of $3.0 billion, compared to the consensus revenue estimate of $3.04 billion.Acadia Healthcare also updated its FY 2018 guidance to $2.25-2.27 EPS.
What price target have analysts set for ACHC?
12 brokerages have issued 1 year price targets for Acadia Healthcare's shares. Their predictions range from $27.00 to $45.00. On average, they expect Acadia Healthcare's stock price to reach $40.3636 in the next twelve months. This suggests a possible upside of 39.2% from the stock's current price. View Analyst Price Targets for Acadia Healthcare.
What is the consensus analysts' recommendation for Acadia Healthcare?
12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Acadia Healthcare in the last year. There are currently 8 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Acadia Healthcare.
What are Wall Street analysts saying about Acadia Healthcare stock?
Here are some recent quotes from research analysts about Acadia Healthcare stock:
- 1. Cantor Fitzgerald analysts commented, "We rate ACHC Neutral primarily to reflect our view of the uncertainty associated with the recovery of its U.K. business, which accounts for 40% of the company’s revenue. $39 price target is based on comparable-company analysis and our DCF. The Disclosure Section may be found on pages 3 – 4.Valuation Our $39 price target reflects our reservations about the company’s ability to grow both organically and through acquisitions." (11/16/2018)
- 2. According to Zacks Investment Research, "Acadia Healthcare’s earnings of 55 cents per share lagged the Zacks Consensus Estimate by 15% and were also down 5.2% year over year. The bottom-line miss was due to rise in expenses that drained EBITDA margin. The company’s operating performance has been favorable for the past many years with consistently rising revenues. It is in the process of opening approximately 800 new beds to existing facilities and new facilities in 2018, which should further fuel its top-line growth. Shares of the company have outperformed the industry year to date. The company is well-positioned for long-term growth on the back of its inorganic strategies. However, it suffers high debt, escalating interest expenses and foreign exchange fluctuations. Substantial integration risks associated with the company’s frequent acquisitions are its major headwinds." (11/12/2018)
Has Acadia Healthcare been receiving favorable news coverage?
Headlines about ACHC stock have trended extremely positive on Saturday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Acadia Healthcare earned a news sentiment score of 4.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 2.0 out of 10, meaning that recent news coverage is very unlikely to have an effect on the stock's share price in the near term.
Who are some of Acadia Healthcare's key competitors?
Some companies that are related to Acadia Healthcare include Canopy Growth (CGC), Genmab A/S (GNMSF), Sino Biopharmaceutical (SBMFF), Sunny Optical Technology (Group) (SNPTF), Steris (STE), Davita (DVA), EXACT Sciences (EXAS), DENTSPLY SIRONA (XRAY), H. Lundbeck A/S- (HLUYY), Molina Healthcare (MOH), Beigene (BGNE), Qiagen (QGEN), Alnylam Pharmaceuticals (ALNY), Sarepta Therapeutics (SRPT) and WILLIAM DEMANT/ADR (WILYY).
Who are Acadia Healthcare's key executives?
Acadia Healthcare's management team includes the folowing people:
- Mr. William Brent Turner, Pres (Age 53)
- Mr. David M. Duckworth, CFO, Chief Accounting Officer & Controller (Age 39)
- Mr. Ronald Morgon Fincher, Chief Operating Officer (Age 66)
- Mr. Christopher L. Howard, Exec. VP, Gen. Counsel & Sec. (Age 52)
- Ms. Debbie Osteen, CEO & Director (Age 64)
Who are Acadia Healthcare's major shareholders?
Acadia Healthcare's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Skyline Asset Management LP (0.42%), Retirement Systems of Alabama (0.13%), Louisiana State Employees Retirement System (0.03%) and Cumberland Advisors Inc. (0.03%). Company insiders that own Acadia Healthcare stock include Brent Turner, Christopher L Howard, Joey A Jacobs, Randall P Goldberg, Reeve B Waud, Ronald Morgan Fincher, Scott Schwieger and William Grieco. View Institutional Ownership Trends for Acadia Healthcare.
Which institutional investors are selling Acadia Healthcare stock?
ACHC stock was sold by a variety of institutional investors in the last quarter, including Skyline Asset Management LP and Louisiana State Employees Retirement System. Company insiders that have sold Acadia Healthcare company stock in the last year include Randall P Goldberg and Reeve B Waud. View Insider Buying and Selling for Acadia Healthcare.
Which institutional investors are buying Acadia Healthcare stock?
How do I buy shares of Acadia Healthcare?
Shares of ACHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Acadia Healthcare's stock price today?
One share of ACHC stock can currently be purchased for approximately $28.99.
How big of a company is Acadia Healthcare?
Acadia Healthcare has a market capitalization of $2.58 billion and generates $2.84 billion in revenue each year. The company earns $199.83 million in net income (profit) each year or $2.30 on an earnings per share basis. Acadia Healthcare employs 40,600 workers across the globe.
What is Acadia Healthcare's official website?
How can I contact Acadia Healthcare?
Acadia Healthcare's mailing address is 6100 TOWER CIRCLE SUITE 1000, FRANKLIN TN, 37067. The company can be reached via phone at 615-861-6000.
MarketBeat Community Rating for Acadia Healthcare (NASDAQ ACHC)
MarketBeat's community ratings are surveys of what our community members think about Acadia Healthcare and other stocks. Vote "Outperform" if you believe ACHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
